SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
47How XOMA views it's HUMab technology. Not endorsing this view just posting aknahow-9/6/2000
46Duly noted. My criticism, in the past, has been that Mitch was slow, IMO, to rescaram(o)uche-9/6/2000
45Nigel--IMGN is a bonafide technology platform biotech company based on their tumJOEBT1-9/6/2000
44Sept. 6 /PRNewswire/ -- ImmunoGen, Inc. (Nasdaq: IMGN - news) and Abgenix, Inc. nigel bates-9/6/2000
43Link from U.K. should provide insights on subject of HuMabs. molbiol.ox.ac.ukaknahow-9/3/2000
42Interesting company with 'pseudo antibodies' ... Message 14268517 nignigel bates-8/24/2000
41Bio world article...Nigel bioworld.comluis a. garcia-8/20/2000
40Aug. 16 /PRNewswire/ -- Medarex, Inc. (Nasdaq: MEDX - news) and Athersys, Inc. anigel bates-8/16/2000
39SAN DIEGO, Aug. 15 /PRNewswire/ -- Avanir Pharmaceuticals, today announced the fnigel bates-8/16/2000
38Aug. 15 /PRNewswire/ -- CuraGen Corporation (Nasdaq: CRGN - news), an integratednigel bates-8/15/2000
37Nigel, On a rest day from climbing, I've been digging through Medscape'tuck-8/12/2000
36Aug. 8, 2000--Abgenix, Inc. (Nasdaq:ABGX - news), and SangStat, The Transplant Cnigel bates-8/8/2000
35Still waiting for the MEDX announcement, but this looks VERY interesting - Messnigel bates-8/7/2000
34More on the 25-th anniversary of MAbs from <i>Immunology Today</i>: Pseudo Biologist-8/1/2000
33<i>I assume this is rethorical</i> No, not at all. When at Cutter,scaram(o)uche-7/22/2000
32<i> ... are they sensitized to allotypes? </i> I assume this is retPseudo Biologist-7/21/2000
31re. "Clark" discussion..... Patients have been receiving massive exposcaram(o)uche-7/21/2000
30Well, it seems the 25-th anniversary of MAbs was just about a week ago. Here isPseudo Biologist-7/21/2000
29George, excellent job. Here is a dialog in the "Biotech Rumor Mill" iPseudo Biologist-7/20/2000
28If you have not yet asked a question to a company using the Wall Street Transcriaknahow-7/12/2000
27July 6 /PRNewswire/ -- MorphoSys AG, the Munich-based biotechnology company, todnigel bates-7/6/2000
26Monoclonal antibodies were referred to as magic bullets back when it was believeReturn to Sender-7/5/2000
25IMGN uses humanized MABS and has been in phase I/II testing for nearly 8 months.Chi Wong-7/5/2000
24"Humanized vs Fully human....Is there a significant difference if both are nigel bates-7/5/2000
23You may very well be right, Luis. I have to say that the chart doesn't lootom pope-7/4/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News